Block on Trump's Asylum Ban Upheld by Supreme Court
The U.S. Food and Drug Administration (FDA) has determined that a professional mailer on Cymbalta from manufacturer Eli Lilly and Co. is "false and misleading" in that it "overstates the efficacy of Cymbalta and omits some of the most serious and important risk information associated with its use" in violation of federal law. FDA has ordered Lilly to cease dissemination of these promotional materials. Cymbalta has been approved for treatment of major depressive disorder, management of pain associated with diabetes, and treatment of generalized anxiety disorder.
Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.
Sign into your Legal Forms and Services account to manage your estate planning documents.Sign In
Create an account allows to take advantage of these benefits: